Metadoxine: Completed Phase II enrollment

Alcobra completed enrollment of 36 patients with predominantly inattentive ADHD in a double-blind, crossover, Israeli

Read the full 152 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE